BEGIN:VCALENDAR
VERSION:2.0
PRODID: -//Q4 Inc.//EN
METHOD:PUBLISH
BEGIN:VTIMEZONE
TZID:America/New_York
X-LIC-LOCATION:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:19700308T020000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=2SU
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:19701101T020000
RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
ORGANIZER:MAILTO:info@redhillbio.com
DTSTART;TZID="America/New_York":20211007T083000
DTEND;TZID="America/New_York":20211012T093000
LOCATION:
UID:954aef28-c18a-4d9c-bccf-a0a115a3ddcd
DTSTAMP:20260413T001650
SUMMARY:Opaganib Phase 2/3 COVID-19 Data Webcast
DESCRIPTION: View More Information: https://www.redhillbio.com/investors/events-and-presentations/event-details/2021/RedHill-Biopharma-Reports-Further-Analysis-of-COVID-19-Phase-2-3-Data-Conference-Call-and-Webcast-/default.aspx
URL;VALUE=URI:https://www.redhillbio.com/investors/events-and-presentations/event-details/2021/RedHill-Biopharma-Reports-Further-Analysis-of-COVID-19-Phase-2-3-Data-Conference-Call-and-Webcast-/default.aspx
PRIORITY:5
CLASS:PUBLIC
END:VEVENT
END:VCALENDAR